Pharmaceuticals
Samsung Biologics snags $1.5bn in orders on pandemic rush
South Korean drug-making powerhouse sees stock price double this year
South Korean drug-making powerhouse sees stock price double this year
Daiichi Sankyo to distribute doses if UK development is successful
AnGes-led team ramps up capacity while product is still under development
South Korean drugmaker to start clinical test for anticancer treatment next year
Products are sold in Australia, Malaysia, Philippines, Singapore and Thailand
Japanese biotech company reduces typical 1-day wait for results
Your weekly lineup of Asia's biggest business and political news
Manufacturer produces compound for boosting vaccine candidate's effectiveness
Jay Y. Lee faces a return to jail two years after being released from detention
South Korean pharmaceutical records 100-fold viral load reduction
Stay ahead with our exclusives on Asia;
the most dynamic market in the world.
Stay ahead with our exclusives on Asia
Get trusted insights from experts within Asia itself.
Get trusted insights from experts
within Asia itself.
Stay ahead with our exclusives on Asia; the most dynamic market in the world.
Get trusted insights from experts
within Asia itself.
Offer ends January 31st
You need a subscription to...
You need a subscription to:
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.
By continuing to browse this website, you accept cookies which are used for several reasons such as personalizing content/ads and analyzing how this website is used. Please review our Cookie Policy to learn how you can update your cookie settings.
Accept & Continue Close